Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes

Angela Orcurto; Andreas Hottinger; Benita Wolf; Blanca Navarro Rodrigo; Maria Ochoa de Olza; Aymeric Auger; Thierry Kuntzer; Denis Comte; Virginie Zimmer; Philippe Gannon; Lana Kandalaft; Olivier Michielin; Stefan Zimmermann; Alexandre Harari; Lionel Trueb; George Coukos

doi:10.1136/jitc-2020-001155

Article info

PDF

XML

Case report

Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes

Authors

Angela Orcurto Immuno-oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
Andreas Hottinger Oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland Service of Neurology, Department of Clinical Neurosciences, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
Benita Wolf Oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
Blanca Navarro Rodrigo Immuno-oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Vaud, Switzerland PubMed articles Google scholar articles
Maria Ochoa de Olza Immuno-oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Vaud, Switzerland PubMed articles Google scholar articles
Aymeric Auger Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Vaud, Switzerland Center of Experimental Therapeutics, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
Thierry Kuntzer Service of Neurology, Department of Clinical Neurosciences, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
Denis Comte Service of Immunology and Allergy, Department of Medicine, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
Virginie Zimmer Center of Experimental Therapeutics, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
Philippe Gannon Center of Experimental Therapeutics, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
Lana Kandalaft Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Vaud, Switzerland Center of Experimental Therapeutics, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
Olivier Michielin Oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
Stefan Zimmermann Immuno-oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
Alexandre Harari Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Vaud, Switzerland Center of Experimental Therapeutics, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
Lionel Trueb Immuno-oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland PubMed articles Google scholar articles
George Coukos Immuno-oncology Service, Department of Oncology, CHUV, Lausanne, Vaud, Switzerland Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Vaud, Switzerland PubMed articles Google scholar articles

Correspondence to Dr Angela Orcurto; angela.orcurto{at}chuv.ch

View Full Text

Citation

Orcurto A, Hottinger A, Wolf B, et al

Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes

Journal for ImmunoTherapy of Cancer 2020;8:e001155. doi: 10.1136/jitc-2020-001155

Publication history

Accepted July 24, 2020
First published August 26, 2020.

Online issue publication

August 26, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password